Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study

被引:3
|
作者
Yue, Rongbin [1 ]
Liu, Xiqiang [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Div Hepatol, Zhuhai, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Hepatic artery infusion chemotherapy; Liver function; Postoperation; POSTOPERATIVE TACE; TUMOR THROMBUS; FAILURE; 5-FLUOROURACIL; PROGNOSIS; MRI; HCC;
D O I
10.1159/000528750
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Liver surgery leads to a high degree of heterogeneity in the prognosis of hepatocellular carcinoma (HCC) patients. However, most previous studies focused on the postoperative therapeutic effects of other treatments, with relatively few studies on the impacts on liver function. This study investigated the impact of transarterial chemoembolization (TACE) and hepatic artery infusion chemotherapy (HAIC) on liver function after HCC resection from various angles. Methods: 138 HCC patients were enrolled, including 27 patients who received TACE and 80 patients who received HAIC. Besides routine treatment such as liver protection and antiviral therapy, 31 patients received no other treatment. The different groups were compared with various biological parameters with four types of scoring methods. Results: In the short term after TACE, the mean (+/- SD) alanine transaminase and aspartate transaminase values increased by 79.22 +/- 117.43 U/L and 66.33 +/- 94.54 U/L, respectively (p < 0.01). The mean (+/- SD) total bilirubin (TBIL) values increased by 4.02 +/- 6.08 mu mol/L (p < 0.01). The mean (+/- SD) albumin (ALB) values decreased by 3.54 +/- 2.93 g/L (p < 0.001). The mean (+/- SD) albumin bilirubin (ALBI) scores increased by 0.39 +/- 0.22 (p < 0.001). In the short term after HAIC, the mean (+/- SD) TBIL values increased by 2.11 +/- 5.57 mu mol/L (p < 0.01). The mean (+/- SD) ALB values decreased by 2.52 +/- 3.26 g/L (p < 0.001), and the mean (+/- SD) ALBI scores increased by 0.21 +/- 0.42 (p < 0.001). In both treatment groups, the long-term liver function was not significantly different from that before treatment and also from that of the untreated group (p > 0.05). Conclusion: TACE after HCC resection has a significant impact on short-term liver function, whereas HAIC has a relatively small impact, but neither has a major impact on long-term liver function.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 50 条
  • [1] Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
    Fukumori, Kazuta
    Yan, Yoichi
    Ando, Eiji
    Sumie, Shur
    Kuwaki, Kotoro
    Yamashita, Fumihiko
    Tanaka, Masatoshi
    Sata, Michio
    MOLECULAR MEDICINE REPORTS, 2008, 1 (04) : 521 - 524
  • [2] Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes
    Hien, Phan Nhan
    Chun, Ho Jong
    Oh, Jung Suk
    Kim, Su Ho
    Choi, Byung Gil
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 721 - 729
  • [3] Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
    Dong-Zhi Zhang
    Xiao-Dong Wei
    Xiao-Peng Wang
    World Journal of Gastroenterology, 2015, 21 (15) : 4635 - 4643
  • [4] Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
    Zhang, Dong-Zhi
    Wei, Xiao-Dong
    Wang, Xiao-Peng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4635 - 4643
  • [5] Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study
    Wang, Yuanqi
    Shen, Jingxian
    Feng, Shiting
    Liang, Ruiming
    Lai, Jiaming
    Li, Dongming
    Peng, Baogang
    Wang, Zaiguo
    Huang, Cheng
    Kuang, Ming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (12) : 2220 - 2228
  • [6] Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?
    Kirikoshi, Hiroyuki
    Yoneda, Masato
    Mawatari, Hironori
    Fujita, Koji
    Imajo, Kento
    Kato, Shingo
    Suzuki, Kaori
    Kobayashi, Noritoshi
    Kubota, Kensuke
    Maeda, Shin
    Nakajima, Atsushi
    Saito, Satoru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (16) : 1933 - 1939
  • [7] Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
    Guo, Jian-Hai
    Liu, Shao-Xing
    Gao, Song
    Kou, Fu-Xin
    Zhang, Xin
    Wu, Di
    Li, Xiao-Ting
    Chen, Hui
    Wang, Xiao-Dong
    Liu, Peng
    Zhang, Peng-Jun
    Xu, Hai-Feng
    Cao, Guang
    Zhu, Lin-Zhong
    Yang, Ren-Jie
    Zhu, Xu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (27) : 3975 - 3988
  • [8] Transarterial chemoembolization as a salvage therapy unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
    Fukumori, Kazuta
    Yano, Yoichi
    Ando, Eiji
    Sumie, Shuji
    Kuwaki, Kotoro
    Yamashita, Fumihiko
    Tanaka, Masatoshi
    Sata, Michio
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S7 - S7
  • [9] Hepatic Decompensation After Transarterial Chemoembolization For Hepatocellular Carcinoma
    Hughes, Dempsey
    Gordon, Fredric D.
    Stuart, Keith E.
    Nugent, F. W.
    Flake, Sebastian
    Simpson, Mary Ann
    Qamar, Amir A.
    HEPATOLOGY, 2015, 62 : 417A - 418A
  • [10] Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
    Jian-Hai Guo
    Shao-Xing Liu
    Song Gao
    Fu-Xin Kou
    Xin Zhang
    Di Wu
    Xiao-Ting Li
    Hui Chen
    Xiao-Dong Wang
    Peng Liu
    Peng-Jun Zhang
    Hai-Feng Xu
    Guang Cao
    Lin-Zhong Zhu
    Ren-Jie Yang
    Xu Zhu
    World Journal of Gastroenterology, 2020, (27) : 3975 - 3988